Not applicableEnded earlyNCT02917759What this trial is testingLiver and Biliary Tumor Tissue RegistryWho this might be right forHepatocellular CarcinomaCholangiocarcinoma Mayo Clinic 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT07186842What this trial is testingA Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9Who this might be right forAdvanced Solid Cancers BioNTech SE 245
Testing effectiveness (Phase 2)Ended earlyNCT00012246What this trial is testingVaccine Therapy in Treating Patients With Cancer of the Gastrointestinal TractWho this might be right forColorectal CancerEsophageal CancerExtrahepatic Bile Duct Cancer+4 more The University of Texas Medical Branch, Galveston 7
Testing effectiveness (Phase 2)Study completedNCT04656249What this trial is testingLenvatinib in Patients With Previously Treated Advanced Biliary Tract CancerWho this might be right forCholangiocarcinomaBiliary Tract CancerTargeted Therapy Peking Union Medical College Hospital 46
Not applicableLooking for participantsNCT07007832What this trial is testingBile Omics for Diagnosing Indeterminate Biliary StricturesWho this might be right forCholangiocarcinomaGallbladder Cancer and Extrahepatic CholangiocarcinomaPancreatic Cancer+2 more Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 260
Large-scale testing (Phase 3)Study completedNCT00363584What this trial is testingCapecitabine or Observation After Surgery in Treating Patients With Biliary Tract CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerLiver Cancer University Hospital Southampton NHS Foundation Trust 360
Not applicableStudy completedNCT06789224What this trial is testingValidation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab DeviceWho this might be right forBladder CarcinomaProstate TumorGallbladder Carcinoma+9 more Lindis Bloodcare GmbH 136
Large-scale testing (Phase 3)Looking for participantsNCT07265674What this trial is testingSelect a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract CancerWho this might be right forAdvanced Biliary Tract CancerBiliary Tract Cancer (BTC) J-Pharma Co., Ltd. 480
Testing effectiveness (Phase 2)Ended earlyNCT04099888What this trial is testingPCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile Duct CancerWho this might be right forCholangiocarcinoma PCI Biotech AS 41
Early research (Phase 1)Study completedNCT00397384What this trial is testingErlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerWho this might be right forAdenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more National Cancer Institute (NCI) 43
Large-scale testing (Phase 3)UnknownNCT01470443What this trial is testingStudy of GEMOX(Gemcitabine/Oxaliplatin) Versus XELOX(Xeloda/Oxaliplatin) in Advanced Biliary Tract CarcinomaWho this might be right forBiliary Tract (Intrahepatic, Extrahepatic Cholangiocarcinoma, Gall Bladder) Cancer Samsung Medical Center 240
Testing effectiveness (Phase 2)WithdrawnNCT00386516What this trial is testingStudy to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder CancerWho this might be right forCancer of the Bile DuctGallbladder Cancer Galectin Therapeutics Inc.
Early research (Phase 1)Looking for participantsNCT07334119What this trial is testingSafety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid TumorsWho this might be right forHER2-Expressing Solid Tumors Myeloid Therapeutics 60
Not applicableUnknownNCT06349044What this trial is testingA Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies.Who this might be right forHer-2 Negative Adenocarcinoma of the Gastro-oesophageal Junction/Gastric AdenocarcinomaHepatocellular CarcinomaBiliary Tract Carcinoma+1 more Zhejiang Cancer Hospital 120
Not applicableEnrolling By InvitationNCT05404503What this trial is testingAnalysis of the Incidence of Cholangiocarcinoma on Choledochal Cyst in a Western CenterWho this might be right forIncidence of Cholangiocarcinoma on Choledochal CystsPostoperative Complications in Choledochal CystsCholedochal Cyst Monitoring María Teresa Moreno Asencio 300
Testing effectiveness (Phase 2)Looking for participantsNCT06638931What this trial is testingAgnostic Therapy in Rare Solid TumorsWho this might be right forUrachal CancerParathyroid CarcinomaFibrolamellar Carcinoma+38 more Instituto do Cancer do Estado de São Paulo 28
Testing effectiveness (Phase 2)Study completedNCT00660699What this trial is testingA Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary CancersWho this might be right forCholangiocarcinoma CancerGallbladder CancerPancreatic Cancer+1 more Washington University School of Medicine 50
Testing effectiveness (Phase 2)Study completedNCT00075504What this trial is testingTriapine and Gemcitabine Hydrochloride in Gallbladder CancerWho this might be right forStage II Gallbladder CancerStage IIIA Gallbladder CancerStage IIIB Gallbladder Cancer+2 more National Cancer Institute (NCI) 33
Testing effectiveness (Phase 2)Study completedNCT00661830What this trial is testingGemcitabine and Sorafenib in Advanced Biliary Tract Cancer (GEMSO)Who this might be right forAdenocarcinoma PD Dr Markus Möhler 103
Not applicableStudy completedNCT04385147What this trial is testingAdvanced Endoscopy During COVID-19Who this might be right forCholangitis, Secondary BiliaryCholangiocarcinomaObstructive Jaundice+3 more Al-Azhar University 670